Key facts
- This page summarizes Stuart A. Arbuckle's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2025, 16:16.
Stuart A. Arbuckle - 01 Jul 2025 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Reporting relationship
- EVP, COO
- Issuer ticker
- VRTX
- Reported as of
- 01 Jul 2025
- Net transaction value
- -$16,767,916
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2025, 16:16:51 UTC
- Prior SEC filing
- 26 Jun 2025
- Next SEC filing
- 07 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christiana Stevenson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stuart A. Arbuckle filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 02 Jul 2025.
Change
- Previous filing in this sequence was filed on 26 Jun 2025.
- Current net transaction value: -$16,767,916.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001557290
Primary reporting owner
Arbuckle Stuart A
- Relationship
- EVP, COO
- Address
- C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON
- Signature
- /s/ Christiana Stevenson, Attorney-in-Fact
- Signature date
- 02 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRTX
transaction
Common Stock
Tax liability
- Transaction value
- $16,767,916
- Shares
- -37,243
- Change %
- -37%
- Price
- $450.23
- Shares after
- 63,368
- Date
- 01 Jul 2025
- Ownership
- Direct
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 140
- Date
- 01 Jul 2025
- Ownership
- 401(k)
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Stuart A. Arbuckle is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.